MicroPort CardioFlow Medtech Corporation provided consolidated revenue guidance for the year ended December 31, 2023. The group is expected to record a revenue of RMB 330 million to RMB 340 million for the year ended December 31, 2023, representing an increase of approximately 31% to 36% as compared to RMB 251 million for the year ended December 31, 2022.
MicroPort CardioFlow Medtech Corporation
Equities
2160
KYG6082P1054
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 HKD | +1.79% | +1.79% | -29.63% |
05-10 | MicroPort CardioFlow Medtech's Medical Device Secures Breakthrough Designation from FDA | MT |
04-16 | Microport Cardioflow Inks Services Deal with Subsidiary | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.63% | 352M | |
+10.39% | 126B | |
+2.52% | 8.97B | |
+38.96% | 5.56B | |
-17.50% | 4.99B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.18B | |
-3.00% | 2.16B | |
-21.88% | 1.82B |
- Stock Market
- Equities
- 2160 Stock
- News MicroPort CardioFlow Medtech Corporation
- MicroPort CardioFlow Medtech Corporation Provides Consolidated Revenue Guidance for the Year Ended December 31, 2023